In July 2024, Roadzen launched a key initiative to strengthen its balance sheet, primarily by renegotiating and reducing payables associated with the going-public transaction and short-term debt. To ...
Net income attributable to IES of $56.3 million for the first quarter of fiscal 2025, an increase of 37% compared with $41.0 million for the same quarter of fiscal 2024, and diluted earnings per share ...
The global Oligonucleotide CDMO Market, valued at US$2.33 billion in 2023, is forecasted to grow at a robust CAGR of 21.8%, ...